This study was designed to evaluate the efficacy and safety of Ziabites on glycemic control in type 2 diabetic patients. The samples consisted of 31 subjects and the doses of Ziabites were equally administered orally in the form of capsule before the breakfast, lunch and dinner. The doses were given for 4 weeks. Ziabites capsule contains Portulaca oleracea L.Rhus coriaria L. and Punica granatum L. The efficacy was assessed on the basis of the following parameters: fasting blood glucose (FBG), 2 h postprandial plasma glucose (2hppG), serum fructosamine, triglyceride (TG) and total cholesterol (Tc) levels. Also, side effects were assessed by history and physical and biochemical examinations. All of the assays were performed on the starting day of study and after 4 weeks. After 4 weeks of treatment with Ziabites capsule, there was a significant decrease (P<0.05) in mean FBG and 2hppG levels when compared with its levels on starting day. Data of mean serum fructosamine levels, showed no significant different between the starting day and after 4 weeks. Also, the reductions of mean serum TG and Tc levels after treatment, were not significant (P>0.05). This study indicated that Ziabites capsule is effective in decreasing fasting and postprandial plasma glucose levels among type 2 diabetic patients without any side effects.
Key words: Ziabites, Portulaca oleracea L., Rhus coriaria L., Punica granatum L., diabetes mellitus.
Copyright © 2019 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0